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Aims and objectives
An exact mediastinal N-staging is essential for therapy stratification in patients with lung cancer, since N3 patients are often excluded from primary surgery. Due to unclear findings in non-invasive staging via FDG-PET/CT and contrast-enhanced computed tomography (CE-CT), it is sometimes mandatory to proceed with invasive staging techniques such as mediastinoscopy, biopsy or surgery (1-3).
Due to the loss of the fatty lymph node hilus in cases of metastatic lymph node infiltration we expected a higher density in affected lymph nodes. The purpose of this study is to assess possible density cut-off values in order to better characterize lymph node invasion in a non-invasive way (Fig 1) . 
Methods and materials
The mediastinal and hilar lymph node status of 45 patients was examined using contrastenhanced CT and FDG-PET/CT. Lymph node density was defined as the primary endpoint and correlated with functional parameters (SUV max ) and histology. After the following mediastinoscopy, transbronchial biopsy or surgery, 60 lymph nodes could clearly be correlated with histology and SUV max .
In order to evaluate lymph node density, metric parameters and histogram analyses were performed using a semi-automated method (4).
Semi-automated 3D histogram analysis of CT-images was performed as follows:
1.
within an estimated region of interest, thresholds were generated automatically by the segmentation software (4).
2.
Spatial parameters were extracted and histogram analysis was performed.
3.
For validation, semi-automated results were verified (implemented 3D viewer for multiplanar reconstruction (Fig 2) ).
4.
Manual correction was possible in all three dimensions. Fig. 2 : Using a semi-automatic method (Fraunhofer MEVIS, Bremen), an estimated region of interest was generated automatically by the segmentation software. Spatial parameters were extracted and histograms were generated.
Fig. 2:

Results
Native CT (derived from PET/CT):
Density of metastatic lymph nodes was signifcantly higher than in non-metastatic lymph nodes (p < 0.05).
More than 90% of the affected lymph nodes had a mean density of more than 20HU. Above a density cut-off value of 20HU the incidence of malignancy was above 75% (Fig.  3) .
Regarding the subgroup of FDG-equivocal lymph nodes, more than 85% of the lymph nodes with a density above 20HU were malignant and 100% of the lymph nodes below the 20HU cut-off were benign.
Contrast-enhanced CT:
Contrast-enhanced CT failed to differentiate affected from non-affected lymph nodes. 
Conclusion
As an additive value for the non-invasive preoperative N-staging a possible cut-off value of 20HU might potentially help to distinguish between affected and non-affected lymph nodes. Volumetric CT-histogram analysis might potentially help to find high yield targets for precise core biopsies, and might therefore potentially reduce the number of futile transbronchial biopsies, mediastinoscopies and thoracotomies.
